Synaptics® Incorporated (Nasdaq: SYNA) today announced the pricing
of its offering of $400.0 million aggregate principal amount of
0.75% convertible senior notes due 2031 (the “notes”) in a private
offering to persons reasonably believed to be qualified
institutional buyers pursuant to Rule 144A under the Securities Act
of 1933, as amended (the “Securities Act”). The issuance and sale
of the notes are scheduled to settle on November 19, 2024, subject
to customary closing conditions. Synaptics also granted the initial
purchasers of the notes an option to purchase, for settlement
within a period of 13 days from, and including, the date the notes
are first issued, up to an additional $50.0 million aggregate
principal amount of notes.
The notes will be senior, unsecured obligations
of Synaptics and will accrue interest at a rate of 0.75% per annum,
payable semi-annually in arrears on June 1 and December 1 of each
year, beginning on June 1, 2025. The notes will mature on December
1, 2031, unless earlier repurchased, redeemed or converted. Before
September 2, 2031, noteholders will have the right to convert their
notes only upon the occurrence of certain events. From and after
September 2, 2031, noteholders may convert their notes at any time
at their election until the close of business on the second
scheduled trading day immediately before the maturity date.
Synaptics will settle conversions in cash and, if applicable,
shares of its common stock. The initial conversion rate is 10.0308
shares of common stock per $1,000 principal amount of notes, which
represents an initial conversion price of approximately $99.69 per
share of common stock. The initial conversion price represents a
premium of approximately 32.5% over the last reported sale price of
$75.24 per share of Synaptics’ common stock on November 14, 2024.
The conversion rate and conversion price will be subject to
adjustment upon the occurrence of certain events.
The notes will be redeemable, in whole or in
part (subject to certain limitations), for cash at Synaptics’
option at any time, and from time to time, on or after December 6,
2028 and on or before the 40th scheduled trading day immediately
before the maturity date, but only if the last reported sale price
per share of Synaptics’ common stock exceeds 130% of the conversion
price for a specified period of time and certain other conditions
are satisfied. The redemption price will be equal to the principal
amount of the notes to be redeemed, plus accrued and unpaid
interest, if any, to, but excluding, the redemption date.
If a “fundamental change” (as defined in the
indenture for the notes) occurs, then, subject to a limited
exception, noteholders may require Synaptics to repurchase their
notes for cash. The repurchase price will be equal to the principal
amount of the notes to be repurchased, plus accrued and unpaid
interest, if any, to, but excluding, the applicable repurchase
date.
Synaptics estimates that the net proceeds from
the offering will be approximately $387.7 million (or approximately
$436.3 million if the initial purchasers exercise in full their
option to purchase additional notes), after deducting the initial
purchasers’ discounts and commissions and Synaptics’ estimated
offering expenses. Synaptics intends to use approximately $44.4
million of the net proceeds to fund the cost of entering into the
capped call transactions described below. Synaptics expects to use
approximately $67.0 million of the net proceeds to repurchase
890,483 shares of its common stock concurrently with the offering
in privately negotiated transactions effected with or through one
of the initial purchasers of the notes or its affiliate. Synaptics
intends to use the remainder of the net proceeds, together with
approximately $307.0 million of cash on hand, to repay the
outstanding balance under its term loan facility. If the initial
purchasers exercise their option to purchase additional notes, then
Synaptics intends to use a portion of the additional net proceeds
to fund the cost of entering into additional capped call
transactions as described below. The concurrent repurchases of
shares of Synaptics’ common stock described above may result in
Synaptics’ common stock trading at prices that are higher than
would be the case in the absence of these repurchases and may have
affected the initial terms of the notes, including the initial
conversion price.
In connection with the pricing of the notes,
Synaptics entered into privately negotiated capped call
transactions with certain of the initial purchasers or their
affiliates and certain other financial institutions (the “option
counterparties”). The capped call transactions will cover, subject
to anti-dilution adjustments, the number of shares of Synaptics’
common stock underlying the notes. If the initial purchasers
exercise their option to purchase additional notes, then Synaptics
expects to enter into additional capped call transactions with the
option counterparties.
The cap price of the capped call transactions is
initially $150.48 per share, which represents a premium of 100.0%
over the last reported sale price of Synaptics’ common stock of
$75.24 per share on November 14, 2024, and is subject to certain
adjustments under the terms of the capped call transactions.
The capped call transactions are expected
generally to reduce the potential dilution to Synaptics’ common
stock upon any conversion of the notes and/or offset any potential
cash payments Synaptics is required to make in excess of the
principal amount of converted notes, as the case may be, with such
offset and/or reduction subject to a cap price. If, however, the
market price per share of Synaptics’ common stock, as measured
under the terms of the capped call transactions, exceeds the cap
price of the capped call transactions, there would nevertheless be
dilution and/or there would not be an offset of such potential cash
payments, in each case, to the extent that such market price
exceeds the cap price of the capped call transactions.
Synaptics has been advised that, in connection
with establishing their initial hedges of the capped call
transactions, the option counterparties or their respective
affiliates expect to enter into various derivative transactions
with respect to Synaptics’ common stock and/or purchase shares of
Synaptics’ common stock concurrently with or shortly after the
pricing of the notes. This activity could increase (or reduce the
size of any decrease in) the market price of Synaptics’ common
stock or the notes at that time.
In addition, the option counterparties and/or
their respective affiliates may modify their hedge positions by
entering into or unwinding various derivatives with respect to
Synaptics’ common stock and/or purchasing or selling Synaptics’
common stock or other securities of Synaptics in secondary market
transactions following the pricing of the notes and prior to the
maturity of the notes (and are likely to do so (x) on each exercise
date for the capped call transactions, which are expected to occur
on each trading day during the 40 trading day period beginning on
the 41st scheduled trading day prior to the maturity date of the
notes and (y) following any early conversion of the notes, any
repurchase of the notes by Synaptics on any fundamental change
repurchase date, any redemption date or any other date on which the
notes are repurchased by Synaptics, in each case if Synaptics
exercises the relevant election to terminate the corresponding
portion of the capped call transactions). This activity could also
cause or avoid an increase or a decrease in the market price of
Synaptics’ common stock or the notes, which could affect the
ability of noteholders to convert the notes, and, to the extent the
activity occurs during any observation period related to a
conversion of the notes, it could affect the number of shares and
value of the consideration that noteholders will receive upon
conversion of the notes.
As described above, Synaptics intends to use a
portion of the net proceeds of the offering to repurchase shares of
its common stock concurrently with the pricing of the offering in
privately negotiated transactions. These repurchases, and any other
repurchases of shares of Synaptics’ common stock, may increase, or
reduce the size of a decrease in, the trading price of Synaptics’
common stock, and repurchases executed concurrently with the
pricing of the offering may have affected the initial terms of the
notes, including the initial conversion price.
The offer and sale of the notes and any shares
of common stock issuable upon conversion of the notes have not
been, and will not be, registered under the Securities Act or any
other securities laws, and the notes and any such shares cannot be
offered or sold except pursuant to an exemption from, or in a
transaction not subject to, the registration requirements of the
Securities Act and any other applicable securities laws. This press
release does not constitute an offer to sell, or the solicitation
of an offer to buy, the notes or any shares of common stock
issuable upon conversion of the notes, nor will there be any sale
of the notes or any such shares, in any state or other jurisdiction
in which such offer, sale or solicitation would be unlawful.
About Synaptics
Synaptics (Nasdaq: SYNA) is leading the charge
in AI at the Edge, bringing AI closer to end users and transforming
how we engage with intelligent connected devices, whether at home,
at work, or on the move. As the go-to partner for the world’s most
forward-thinking product innovators, Synaptics powers the future
with its cutting-edge Synaptics Astra™ AI-Native embedded compute,
Veros™ wireless connectivity, and multimodal sensing solutions.
We’re making the digital experience smarter, faster, more
intuitive, secure, and seamless. From touch, display, and
biometrics to AI-driven wireless connectivity, video, vision,
audio, speech, and security processing, Synaptics is the force
behind the next generation of technology enhancing how we live,
work, and play.
Forward-Looking Statements
This press release includes forward-looking
statements, including statements regarding the completion of the
offering, the expected amount and intended use of the net proceeds
and the effects of entering into the capped call and repurchase
transactions described above. Forward-looking statements represent
Synaptics’ current expectations regarding future events and are
subject to known and unknown risks and uncertainties that could
cause actual results to differ materially from those implied by the
forward-looking statements. Among those risks and uncertainties are
market conditions, the satisfaction of the closing conditions
related to the offering, whether the capped call transactions will
become effective and other factors and risks relating to Synaptics’
business, including those described in periodic reports that
Synaptics files from time to time with the SEC. Synaptics may not
consummate the offering described in this press release and, if the
offering is consummated, cannot provide any assurances regarding
its ability to effectively apply the net proceeds as described
above. The forward-looking statements included in this press
release speak only as of the date of this press release, and
Synaptics does not undertake to update the statements included in
this press release for subsequent developments, except as may be
required by law.
Investor Relations Contact
Munjal ShahHead of Investor Relations+1
408-518-7639munjal.shah@synaptics.com
Media Contact
Patrick MannionDirector of External PR and
Technical Communications+1
631-678-1015patrick.mannion@synaptics.com
Synaptics (NASDAQ:SYNA)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Synaptics (NASDAQ:SYNA)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024